Exometabolome analysis reveals hypoxia at the up-scaling of a Saccharomyces cerevisiae high-cell density fed-batch biopharmaceutical process

Abstract

BackgroundScale-up to industrial production level of a fermentation process occurs after optimization at small scale, a critical transition for successful technology transfer and commercialization of a product of interest. At the large scale a number of important bioprocess engineering problems arise that should be taken into account to match the values obtained at the small scale and achieve the highest productivity and quality possible. However, the changes of the host strain’s physiological and metabolic behavior in response to the scale transition are still not clear.ResultsHeterogeneity in substrate and oxygen distribution is an inherent factor at industrial scale (10,000 L) which affects the success of process up-scaling. To counteract these detrimental effects, changes in dissolved oxygen and pressure set points and addition of diluents were applied to 10,000 L scale to enable a successful process scale-up. A comprehensive semi-quantitative and time-dependent analysis of the exometabolome was performed to understand the impact of the scale-up on the metabolic/physiological behavior of the host microorganism. Intermediates from central carbon catabolism and mevalonate/ergosterol synthesis pathways were found to accumulate in both the 10 L and 10,000 L scale cultures in a time-dependent manner. Moreover, excreted metabolites analysis revealed that hypoxic conditions prevailed at the 10,000 L scale. The specific product yield increased at the 10,000 L scale, in spite of metabolic stress and catabolic-anabolic uncoupling unveiled by the decrease in biomass yield on consumed oxygen.ConclusionsAn optimized S. cerevisiae fermentation process was successfully scaled-up to an industrial scale bioreactor. The oxygen uptake rate (OUR) and overall growth profiles were matched between scales. The major remaining differences between scales were wet cell weight and culture apparent viscosity. The metabolic and physiological behavior of the host microorganism at the 10,000 L scale was investigated with exometabolomics, indicating that reduced oxygen availability affected oxidative phosphorylation cascading into down- and up-stream pathways producing overflow metabolism. Our study revealed striking metabolic and physiological changes in response to hypoxia exerted by industrial bioprocess up-scaling.

Optimization of a multi‐stage, multi‐subunit malaria vaccine candidate for the production in Pichia pastoris by the identification and removal of protease cleavage sites

“…Taking into account that in large scale processes energy dissipation rates (ε T ) for high cell density fermentations are normally applied only up to 5 W/kg because of power restrictions (Nienow, ) and ε T correlates with k L a (Van't Riet, ) we already operated at the upper limit of the OTR (Fuchs and Ryu, ). Higher k L a values are only feasible when additional gassing with cost‐intensive pure oxygen is applied (Fu et al, ). Hence, yields should be assessed taking the process conditions into account.…”

Characterization of a Saccharomyces cerevisiae fermentation process for production of a therapeutic recombinant protein using a multivariate Bayesian approach

“…The S. cerevisiae strain was originally developed from the parental S. cerevisiae strain AH22 (ATCC 38626) and the gene encoding for the product is in a high‐copy number plasmid. The fermentation process to produce a therapeutic recombinant protein, Pr‐1, at the small scale (10 L) was described previously . Briefly, Pr‐1 production is conditionally induced in the host strain by glucose limitation that elicits product secretion into the medium.…”

“…Previously, we presented a stepwise approach to optimize a S. cerevisiae fermentation process and quantifying the reliable operating region of the process using the multivariate Bayesian posterior predictive approach . The optimized fermentation process was further successfully scaled‐up to a 10,000 L scale . This optimization and scale‐up program significantly contributed to process and product knowledge understanding.…”

Regulatory control circuits for stabilizing long-term anabolic product formation in yeast

“…Following another 48 hours, 40 µL of this first seed-train culture was transferred to a 4-mL shake flask culture, and after another 48 hours this culture was used to inoculate a 400-mL bioreactor. This seed train from 40 µL to 400 mL represents the same number of generations encountered in industrial seed trains starting from 1L and ending at 10,000 L (Fu et al, 2014).…”